Cargando…

2272. Evaluation of Clinical Features, Carbapenem Resistance and Risk Factors of Klebsiella Species: A 4-Year Retrospective Study in Turkey

BACKGROUND: Gram-negative-resistant bacterial infections are increasing due to widespread use of antibiotics. Infections caused by Klebsiella spp. are an important part of healthcare-associated infections and cause morbidity and mortality. The aim of this study was to determine the epidemiological,...

Descripción completa

Detalles Bibliográficos
Autores principales: Umit, Zuhal, Sahbudak Bal, Zumrut, Guner, Gizem, Avcu, Gulhadiye, Bozkurt, Duygu, Kurugol, Zafer, Vardar, Fadil, Cilli, Feriha, Ozkinay, Ferda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810062/
http://dx.doi.org/10.1093/ofid/ofz360.1950
_version_ 1783462155492786176
author Umit, Zuhal
Sahbudak Bal, Zumrut
Guner, Gizem
Avcu, Gulhadiye
Bozkurt, Duygu
Kurugol, Zafer
Vardar, Fadil
Cilli, Feriha
Ozkinay, Ferda
author_facet Umit, Zuhal
Sahbudak Bal, Zumrut
Guner, Gizem
Avcu, Gulhadiye
Bozkurt, Duygu
Kurugol, Zafer
Vardar, Fadil
Cilli, Feriha
Ozkinay, Ferda
author_sort Umit, Zuhal
collection PubMed
description BACKGROUND: Gram-negative-resistant bacterial infections are increasing due to widespread use of antibiotics. Infections caused by Klebsiella spp. are an important part of healthcare-associated infections and cause morbidity and mortality. The aim of this study was to determine the epidemiological, clinical features, carbapenem resistance rates and risk factors of bloodstream infections of children with Klebsiella spp. METHODS: In this retropective study, medical records of 85 episodes of 75 patients caused by with Klebsiella spp. bacteriaemia who admitted to Ege University Faculty of Medicine, Pediatric Hospital in Turkey between 2014 and 2017 were evaluated. Conventional biochemical methods were performed using the automated systems of MALDİ-TOFF MS / VITEK 2 (Biomerieux, France). According to EUCAST recommendations, VITEK 2 (Biomerieux, France) automated microdilution method was used in sensitivity tests. RESULTS: The mean age of 85 episodes included in the study was 3.49 (±5.4) years. 58% of the patients were male and 42% were female. 18.8% of the patients were premature. The most common service was newborn service (30.6%). Neutropenia was 26% and thrombocytopenia was 55% at the time of diagnosis. Klebsiella pneumonia was 93% and Klebsiella oxytoca was 7%. Carbapenem resistance rate was found to be 30.6% in Klebsiella spp. Carbapenem resistance was found 18% in 2014, 38% in 2015, 42% in 2016 and 25% in 2017. In patients who developed carbapenem-resistant Klebsiella infection, the duration of pre-hospitalization ≥14 days (P = 0.034), the absolute neutrophil count < 100 (P = 0.048) and steroid use (P = 0.025) were statistically significant risk factors. The mean length of hospital stay was 107 (±103) days. Klebsiella spp. attributable mortality due to infection was 14% and crude mortality was 15%. No statistically significant difference was found in patients who developed resistant and susceptible infections. CONCLUSION: Carbapenem resistance in Klebsiella infections was increased. Prolonged hospital stay, neutropenia and steroid use in the last 3 months were identified as significant risk factors for carbapenem-resistant Klebsiella infections. [Image: see text] DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6810062
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68100622019-10-28 2272. Evaluation of Clinical Features, Carbapenem Resistance and Risk Factors of Klebsiella Species: A 4-Year Retrospective Study in Turkey Umit, Zuhal Sahbudak Bal, Zumrut Guner, Gizem Avcu, Gulhadiye Bozkurt, Duygu Kurugol, Zafer Vardar, Fadil Cilli, Feriha Ozkinay, Ferda Open Forum Infect Dis Abstracts BACKGROUND: Gram-negative-resistant bacterial infections are increasing due to widespread use of antibiotics. Infections caused by Klebsiella spp. are an important part of healthcare-associated infections and cause morbidity and mortality. The aim of this study was to determine the epidemiological, clinical features, carbapenem resistance rates and risk factors of bloodstream infections of children with Klebsiella spp. METHODS: In this retropective study, medical records of 85 episodes of 75 patients caused by with Klebsiella spp. bacteriaemia who admitted to Ege University Faculty of Medicine, Pediatric Hospital in Turkey between 2014 and 2017 were evaluated. Conventional biochemical methods were performed using the automated systems of MALDİ-TOFF MS / VITEK 2 (Biomerieux, France). According to EUCAST recommendations, VITEK 2 (Biomerieux, France) automated microdilution method was used in sensitivity tests. RESULTS: The mean age of 85 episodes included in the study was 3.49 (±5.4) years. 58% of the patients were male and 42% were female. 18.8% of the patients were premature. The most common service was newborn service (30.6%). Neutropenia was 26% and thrombocytopenia was 55% at the time of diagnosis. Klebsiella pneumonia was 93% and Klebsiella oxytoca was 7%. Carbapenem resistance rate was found to be 30.6% in Klebsiella spp. Carbapenem resistance was found 18% in 2014, 38% in 2015, 42% in 2016 and 25% in 2017. In patients who developed carbapenem-resistant Klebsiella infection, the duration of pre-hospitalization ≥14 days (P = 0.034), the absolute neutrophil count < 100 (P = 0.048) and steroid use (P = 0.025) were statistically significant risk factors. The mean length of hospital stay was 107 (±103) days. Klebsiella spp. attributable mortality due to infection was 14% and crude mortality was 15%. No statistically significant difference was found in patients who developed resistant and susceptible infections. CONCLUSION: Carbapenem resistance in Klebsiella infections was increased. Prolonged hospital stay, neutropenia and steroid use in the last 3 months were identified as significant risk factors for carbapenem-resistant Klebsiella infections. [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6810062/ http://dx.doi.org/10.1093/ofid/ofz360.1950 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Umit, Zuhal
Sahbudak Bal, Zumrut
Guner, Gizem
Avcu, Gulhadiye
Bozkurt, Duygu
Kurugol, Zafer
Vardar, Fadil
Cilli, Feriha
Ozkinay, Ferda
2272. Evaluation of Clinical Features, Carbapenem Resistance and Risk Factors of Klebsiella Species: A 4-Year Retrospective Study in Turkey
title 2272. Evaluation of Clinical Features, Carbapenem Resistance and Risk Factors of Klebsiella Species: A 4-Year Retrospective Study in Turkey
title_full 2272. Evaluation of Clinical Features, Carbapenem Resistance and Risk Factors of Klebsiella Species: A 4-Year Retrospective Study in Turkey
title_fullStr 2272. Evaluation of Clinical Features, Carbapenem Resistance and Risk Factors of Klebsiella Species: A 4-Year Retrospective Study in Turkey
title_full_unstemmed 2272. Evaluation of Clinical Features, Carbapenem Resistance and Risk Factors of Klebsiella Species: A 4-Year Retrospective Study in Turkey
title_short 2272. Evaluation of Clinical Features, Carbapenem Resistance and Risk Factors of Klebsiella Species: A 4-Year Retrospective Study in Turkey
title_sort 2272. evaluation of clinical features, carbapenem resistance and risk factors of klebsiella species: a 4-year retrospective study in turkey
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810062/
http://dx.doi.org/10.1093/ofid/ofz360.1950
work_keys_str_mv AT umitzuhal 2272evaluationofclinicalfeaturescarbapenemresistanceandriskfactorsofklebsiellaspeciesa4yearretrospectivestudyinturkey
AT sahbudakbalzumrut 2272evaluationofclinicalfeaturescarbapenemresistanceandriskfactorsofklebsiellaspeciesa4yearretrospectivestudyinturkey
AT gunergizem 2272evaluationofclinicalfeaturescarbapenemresistanceandriskfactorsofklebsiellaspeciesa4yearretrospectivestudyinturkey
AT avcugulhadiye 2272evaluationofclinicalfeaturescarbapenemresistanceandriskfactorsofklebsiellaspeciesa4yearretrospectivestudyinturkey
AT bozkurtduygu 2272evaluationofclinicalfeaturescarbapenemresistanceandriskfactorsofklebsiellaspeciesa4yearretrospectivestudyinturkey
AT kurugolzafer 2272evaluationofclinicalfeaturescarbapenemresistanceandriskfactorsofklebsiellaspeciesa4yearretrospectivestudyinturkey
AT vardarfadil 2272evaluationofclinicalfeaturescarbapenemresistanceandriskfactorsofklebsiellaspeciesa4yearretrospectivestudyinturkey
AT cilliferiha 2272evaluationofclinicalfeaturescarbapenemresistanceandriskfactorsofklebsiellaspeciesa4yearretrospectivestudyinturkey
AT ozkinayferda 2272evaluationofclinicalfeaturescarbapenemresistanceandriskfactorsofklebsiellaspeciesa4yearretrospectivestudyinturkey